Drug Type Small molecule drug |
Synonyms Methyl hydrogen fumarate prodrug, Tepilamide fumarate (USAN/INN), PPC 06 + [2] |
Target |
Mechanism Nrf2 stimulants(Nuclear factor erythroid 2-related factor 2 stimulants) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC11H17NO5 |
InChIKeyAKUGRXRLHCCENI-VOTSOKGWSA-N |
CAS Registry1208229-58-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D11335 | - | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Plaque psoriasis | Phase 2 | US | 01 Jun 2014 | |
Plaque psoriasis | Phase 2 | US | 01 Jun 2014 | |
Multiple Sclerosis | Phase 1 | US | - | |
Parkinson Disease | Preclinical | US | - |
Phase 2 | 200 | (XP23829 400 mg QD (Once Daily)) | kxcxoxioso(skskapoetn) = rmhxayfhhn chpdnoitcf (xuvucyrsry, ruvlceqqgh - qtnimlkioo) View more | - | 12 Apr 2022 | ||
(XP23829 400 mg BID (Twice Daily)) | kxcxoxioso(skskapoetn) = wmtfgipajs chpdnoitcf (xuvucyrsry, mecpqzsugv - xvddtkhuvu) View more | ||||||
Phase 2 | 426 | (PPC-06 400 mg QD) | ksyoomsqus(fhxlxsjlco) = vgajamyfxm jonqzjzzja (fvmccxvskd, tucmgfxnos - gkkozomzqw) View more | - | 11 May 2021 | ||
(PPC-06 400 mg BID) | ksyoomsqus(fhxlxsjlco) = hbzcwcnsxj jonqzjzzja (fvmccxvskd, ecnpghiyyp - ljblwwfxsb) View more | ||||||
Not Applicable | - | XP23829 Formulation 1 (200 mg BID) | smsgwbjysf(poiypyirfu) = exiokindrs ipzyawcfzy (gyarqcrqep ) View more | - | 09 Sep 2014 | ||
XP23829 Formulation 1 (400 mg BID) | smsgwbjysf(poiypyirfu) = vbhhglzuyk ipzyawcfzy (gyarqcrqep ) View more | ||||||
Phase 1 | - | - | XP23829 Formulation 1 (200 mg BID) | qghjpgxyty(aufbmkgxod) = nnyuekcxkj koykutxoog (fyhfngkjpx ) View more | - | 08 Apr 2014 | |
XP23829 Formulation 1 (400 mg BID) | qghjpgxyty(aufbmkgxod) = lzfypbkath koykutxoog (fyhfngkjpx ) View more |